Home › Funds › EcoR1 Capital, LLC › STOK
EcoR1 Capital, LLC position in STOK
STOKE THERAPEUTICS INC · Health Care
EcoR1 Capital, LLC reported holding 835,000 shares of STOK (STOKE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$21.7M, representing 1.03% of its reported portfolio and ranking #16 among its reported holdings. EcoR1 Capital, LLC has disclosed STOK holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How EcoR1 Capital, LLC's STOK position evolved
EcoR1 Capital, LLC first disclosed a stake in STOK in Q1 2026 at 100,000 shares (US$3.3M). The position peaked in Q2 2026 at 735,000 shares, worth US$24.0M. Across 3 filings, EcoR1 Capital, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 835,000 shares valued at US$21.7M — an increase of 100,000 shares quarter over quarter.. Notable position changes include a 635% increase in Q2 2026 (shares fell 21% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 100.00K | $3.26M | New |
| Q2 2026 | 735.00K | $24.05M | Add |
| Q3 2026 | 835.00K | $21.71M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About STOK and 13F data
STOK (STOKE THERAPEUTICS INC) is a Health Care company. 46 other funds we track also report a position in STOK — the largest reported positions include RTW INVESTMENTS, LP (US$146.2M), Lynx1 Capital Management LP (US$132.1M), Redmile Group, LLC (US$129.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding STOK
- RTW INVESTMENTS, LP 5.62M sh · $146.21M · Q3 2026
- Lynx1 Capital Management LP 4.04M sh · $132.14M · Q2 2026
- Redmile Group, LLC 3.95M sh · $129.11M · Q2 2026
- BAKER BROS. ADVISORS LP 3.34M sh · $109.18M · Q2 2026
- TORONTO DOMINION BANK 3.17M sh · $103.83M · Q2 2026
- BVF INC/IL 2.55M sh · $83.36M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.82M sh · $59.66M · Q2 2026
- Siren, L.L.C. 2.00M sh · $51.88M · Q3 2026
- MPM BioImpact LLC 723.31K sh · $23.67M · Q2 2026
- Opaleye Management Inc. 700.00K sh · $22.90M · Q2 2026
- Troluce Capital Advisors LLC 496.42K sh · $16.24M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 300.00K sh · $9.82M · Q2 2026
More on EcoR1 Capital, LLC
FAQ
How long has EcoR1 Capital, LLC held STOK?
EcoR1 Capital, LLC has disclosed STOK holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is EcoR1 Capital, LLC's current position in STOK?
As of Q3 2026, EcoR1 Capital, LLC holds 835.00K shares of STOK (STOKE THERAPEUTICS INC), valued at $21.71M, representing 1.03% of its reported portfolio and ranking #16.
Has EcoR1 Capital, LLC been buying or selling STOK?
In the latest 13F filing (Q3 2026), EcoR1 Capital, LLC increased its position in STOK. The position peaked in Q2 2026 at 735.00K shares.
Which other funds hold STOK?
Other major institutional holders of STOK include RTW INVESTMENTS, LP, Lynx1 Capital Management LP, Redmile Group, LLC, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.